Remote controlled one-step production of 18F labeled butyrophenone neuroleptics exemplified by the synthesis of n.c.a. [18F] N-methylspiperone
暂无分享,去创建一个
[1] J. Mertens,et al. Mechanistic approach of the nucleophilic18F‐ exchange on 4′‐NO2‐spiperone using TBA18F or K2.2.2./K18F , 1990 .
[2] G. Sedvall,et al. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. , 1988, Archives of general psychiatry.
[3] K. Hamacher,et al. Computer-aided synthesis (CAS) of no-carrier-added 2-[18F]fluoro-2-deoxy-D-glucose: an efficient automated system for the aminopolyether-supported nucleophilic fluorination , 1990 .
[4] C. D. Arnett,et al. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] S. Moerlein,et al. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding. , 1992, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[6] A. Wilson,et al. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] J S Fowler,et al. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. , 1985, Life sciences.
[8] C. D. Arnett,et al. Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients , 1988, Biological Psychiatry.
[9] K. Hamacher,et al. Optimization studies concerning the direct nucleophilic fluorination of butyrophenone neuroleptics , 1993 .
[10] H. Coenen,et al. Preparation of N.C.A. [17‐18F]‐fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination , 1986 .
[11] C. D. Arnett,et al. Syntheses and Specific Activity Determinations of No-Carrier-Added Fluorine-18-Labeled Neuroleptic Drugs , 1985 .
[12] T. Cooper,et al. Dopamine receptor occupancy and plasma haloperidol levels. , 1989, Archives of general psychiatry.